Capstone Investment Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-72,322
Closed -$739K 1414
2024
Q1
$739K Buy
+72,322
New +$739K ﹤0.01% 662